This bill would repeal the Robinson-Patman Act of 1936, a federal law that restricts price discrimination in wholesale transactions. The legislation is short and straightforward—it simply eliminates the entire 1936 statute and any amendments made to it. By removing this law, the bill would allow pharmaceutical manufacturers and wholesalers greater flexibility in setting different prices for different buyers, potentially enabling larger pharmacy chains and other bulk purchasers to negotiate deeper discounts than smaller competitors. The bill does not specify any implementation timeline, funding, or exceptions. The proponents argue that repealing this Depression-era antitrust law would reduce prescription drug costs for some consumers, while opponents worry it could harm independent pharmacies and small retailers that lack negotiating power.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.